Bloomberg Markets & Finance via Youtube


Jul.03 — AstraZeneca Plc Chief Executive Officer Pascal Soriot has shifted the company’s focus back to developing medicine, and in the process revitalized its share price.

READ ALSO  New York hospitals told to get ready for coronavirus surge